ISTLTD stock news
This page provides real-time market news, earnings updates, and company announcements related to IST Ltd (ISTLTD).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-10 03:48 IST
Ethereum News Today: Ethereum Price Holds Steady While Major Investors and Institutions Make Significant Long-Term Bets
Bitget-RWA2025-11-16 16:02:05
Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases
Finviz2026-02-12 12:06:41
Virtuix and University of Central Florida Reveal Humanoid Robot Controlled Via Omni One Treadmill
Finviz2026-02-25 12:48:42
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-27 13:03:11
Innoviva, Inc. (INVA): A Bull Case Theory
Finviz2026-02-28 13:27:48
Cantor Fitzgerald Lifts PT on Innoviva, Inc. (INVA) to $32 from $31 - Here's Why
Finviz2026-03-01 09:30:14
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-03-03 21:09:41
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-03-03 21:09:41
BioXcel Therapeutics Announces Positive Phase 2 Topline Results from Columbia University-Led Study of BXCL501 for Treatment of Opioid Withdrawal
Finviz2026-03-05 12:03:12
Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update
Finviz2026-03-05 12:33:49
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-12 11:03:48
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates
Finviz2026-03-12 12:03:53
Kyntra Bio (KYNB) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-16 22:15:47
Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength
Finviz2026-03-25 11:36:45
BioXcel Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results as Company Prepares for Potential IGALMI Approval in Outpatient Setting
Finviz2026-03-27 11:03:57
DiaMedica Therapeutics’ 2025 Earnings Calls Contradict Stroke Enrollment Rates, U.S. Trial Timelines
101 finance2026-03-31 13:24:41
City of Hope Study Validates FENEC’s PEDMARK Expansion Play—Event-Driven Setup Building
101 finance2026-04-07 11:28:01
Innoviva, Inc. (INVA): A Bull Case Theory
Finviz2026-02-28 13:27:48
Cantor Fitzgerald Lifts PT on Innoviva, Inc. (INVA) to $32 from $31 - Here's Why
Finviz2026-03-01 09:30:14
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-03-03 21:09:41
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-03-03 21:09:41
BioXcel Therapeutics Announces Positive Phase 2 Topline Results from Columbia University-Led Study of BXCL501 for Treatment of Opioid Withdrawal
Finviz2026-03-05 12:03:12
Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update
Finviz2026-03-05 12:33:49
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-12 11:03:48
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates
Finviz2026-03-12 12:03:53
Kyntra Bio (KYNB) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-16 22:15:47
Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength
Finviz2026-03-25 11:36:45
BioXcel Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results as Company Prepares for Potential IGALMI Approval in Outpatient Setting
Finviz2026-03-27 11:03:57
DiaMedica Therapeutics’ 2025 Earnings Calls Contradict Stroke Enrollment Rates, U.S. Trial Timelines
101 finance2026-03-31 13:24:41
City of Hope Study Validates FENEC’s PEDMARK Expansion Play—Event-Driven Setup Building
101 finance2026-04-07 11:28:01
ISTLTD stock price change
On the last trading day, ISTLTD stock closed at 694.55 INR, with a price change of 2.29% for the day.
Trade stock perpsISTLTD stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more